Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
EDAP TMS ( (EDAP) ) just unveiled an announcement.
EDAP TMS announced the appointment of Joshua H. Levine to its Board of Directors, bringing his extensive executive experience in the medical technology sector to the company. Levine’s strategic insight is expected to support EDAP’s growth and expansion of its Focal One platform, which has been transforming treatment paradigms in prostate cancer and holds promise for other medical indications.
More about EDAP TMS
EDAP TMS SA is a global leader in robotic energy-based therapies, specializing in the development, manufacture, and distribution of minimally invasive medical devices using ultrasound technology. Known for its Focal One robotic HIFU platform, EDAP TMS focuses on prostate focal therapy with potential applications in other therapeutic areas.
YTD Price Performance: -8.33%
Average Trading Volume: 165,674
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $81.63M
Learn more about EDAP stock on TipRanks’ Stock Analysis page.
